Active Ingredient History
Astaxanthin is a keto-carotenoid within a group of chemical compounds known as terpenes. Astaxanthin is a metabolite of zeaxanthin and canthaxanthin, containing both hydroxyl and ketone functional groups. It is a lipid-soluble pigment with red coloring properties, which result from the extended chain of conjugated double bonds at the center of the compound. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acne Vulgaris (Phase 3)
Alopecia (Phase 3)
Atherosclerosis (Phase 4)
Dermatology (Phase 3)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Neuropathies (Phase 2/Phase 3)
Diabetic Retinopathy (Phase 3)
Healthy Volunteers (Early Phase 1)
Hypercholesterolemia (Phase 4)
Hypertrophy, Left Ventricular (Phase 4)
Inflammation (Phase 4)
Malondialdehyde (Phase 1)
Metabolic Syndrome (Phase 1)
Nails (Phase 3)
Osteoarthritis (Phase 2/Phase 3)
Osteoarthritis, Knee (Phase 2/Phase 3)
Oxidative Stress (Phase 2)
Skin Aging (Phase 3)
Stroke (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue